019170.KS

Shin Poong Pharm.Co.,Ltd. [019170.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

019170.KS Stock Summary

Top 10 Correlated ETFs

019170.KS


Top 10 Correlated Stocks

019170.KS


In the News

019170.KS Financial details

Company Rating
Buy
Market Cap
653.83B
Income
-41.06B
Revenue
209.41B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
828
Optionable
No
Shortable
Yes
Earnings
14 Nov 2023
P/E
-16
Forward P/E
-
PEG
-0.6
P/S
3.1
P/B
2.15
P/C
-
P/FCF
-15.51
Quick Ratio
-
Current Ratio
2.97
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-820.41
EPS next Y
-
EPS next Q
-
EPS this Y
220.09%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
2.24%
Revenue Q/Q
-7.5%
EPS Q/Q
-10.76%
-
-
-
-
SMA20
2.27%
SMA50
-19.19%
SMA100
-16.36%
Inst Own
-
Inst Trans
-
ROA
-11%
ROE
-13%
ROC
-0.13%
Gross Margin
40%
Oper. Margin
-20%
Profit Margin
-20%
Payout
-
Shs Outstand
49.27M
Shs Float
34.01M
-
-
-
-
Target Price
-
52W Range
9560.0-24000.0
52W High
-45.38%
52W Low
+37.13%
RSI
50.79
Rel Volume
0.43
Avg Volume
286.77K
Volume
122.56K
Perf Week
3.55%
Perf Month
10.63%
Perf Quarter
-21.12%
Perf Half Y
-23.65%
-
-
-
-
Beta
0.895
-
-
Volatility
360.91%, 531.88%
Prev Close
-1.21%
Price
13110
Change
-2.89%

019170.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
3.74K3.81K3.95K3.68K4.25K
Net income per share
56107100-223.88-716.62
Operating cash flow per share
640.22388.91401.02-1.38K-536.7
Free cash flow per share
603.48103.92338.66-1.49K-663.12
Cash per share
1.33K1.33K3.81K1.8K1.13K
Book value per share
4.12K4.18K7.46K6.87K6.69K
Tangible book value per share
4K4.02K7.32K6.71K6.57K
Share holders equity per share
4.12K4.18K7.46K6.87K6.69K
Interest debt per share
2.23K2.22K94.5526.8656
Market cap
313.42B360.23B6203.48B1644.87B1010.06B
Enterprise value
383.69B443.35B6149.46B1618.42B970.29B
P/E ratio
111.7967.661.24K-142.71-28.61
Price to sales ratio
1.671.931.378.694.83
POCF ratio
9.7818.62309.21-23.16-38.2
PFCF ratio
10.3769.67366.15-21.46-30.91
P/B Ratio
1.521.7316.614.653.06
PTB ratio
1.521.7316.614.653.06
EV to sales
2.052.3431.18.554.64
Enterprise value over EBITDA
17.421.38261.05445.812.44
EV to operating cash flow
11.9722.91306.52-22.79-36.69
EV to free cash flow
12.785.74362.97-21.12-29.7
Earnings yield
0.010.010-0.01-0.03
Free cash flow yield
0.10.010-0.05-0.03
Debt to equity
0.520.51000.01
Debt to assets
0.280.28000.01
Net debt to EBITDA
3.194.01-2.29-7.29-0.51
Current ratio
1.541.643.997.967.23
Interest coverage
2.52.053.85-44.76-40.94
Income quality
11.393.593.986.160.75
Dividend Yield
00000
Payout ratio
000-0.450
Sales general and administrative to revenue
0.030.030.030.030.54
Research and developement to revenue
0.030.030.030.090.15
Intangibles to total assets
0.020.020.020.020.02
Capex to operating cash flow
-0.06-0.73-0.160.080.24
Capex to revenue
-0.01-0.07-0.02-0.03-0.03
Capex to depreciation
-0.16-1.15-0.26-0.44-0.49
Stock based compensation to revenue
00000
Graham number
2.28K3.17K4.1K5.88K10.39K
ROIC
0.020.020.02-0.03-0.1
Return on tangible assets
0.010.010.01-0.03-0.1
Graham Net
-6.85-60.763.43K2.78K2.41K
Working capital
78.44B85.24B249.47B198.68B169.37B
Tangible asset value
200.36B200.21B366.27B345.59B323.83B
Net current asset value
51.14B48.21B219.99B189.21B165.76B
Invested capital
0.520.51000.01
Average receivables
120.4B107.57B97.68B89.31B90B
Average payables
23.17B19.77B13.58B10.42B11.74B
Average inventory
45.93B46.98B49.06B48.4B47.3B
Days sales outstanding
218.34198.25170.38166.49163.38
Days payables outstanding
69.2859.0726.4639.3631.77
Days of inventory on hand
147.1157.61147.8155.68130.35
Receivables turnover
1.671.842.142.192.23
Payables turnover
5.276.1813.799.2711.49
Inventory turnover
2.482.322.472.342.8
ROE
0.010.030.01-0.03-0.11
Capex per share
-36.75-284.99-62.37-109.06-126.42

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.08K1.19K981.681.04K0
Net income per share
-188.78-344.96-142.38-1760
Operating cash flow per share
-132.02-378.71-85.384.070
Free cash flow per share
-156.37-398.95-152.11-136.790
Cash per share
1.58K1.13K1.62K1.42K0
Book value per share
6.86K6.69K6.57K6.15K0
Tangible book value per share
6.74K6.57K6.45K6.05K0
Share holders equity per share
6.86K6.69K6.57K6.15K0
Interest debt per share
47.07116.38583.72622.720
Market cap
980.49B1010.06B887.37B812.91B0
Enterprise value
944.42B970.29B869.8B796.16B0
P/E ratio
-26.35-14.86-31.62-22.590
Price to sales ratio
18.3717.1818.3515.30
POCF ratio
-150.74-54.13-210.933.9K0
PFCF ratio
-127.26-51.39-118.4-116.240
P/B Ratio
2.93.062.742.590
PTB ratio
2.93.062.742.590
EV to sales
17.6916.517.9814.990
Enterprise value over EBITDA
-103.659.7845.4236.350
EV to operating cash flow
-145.19-52-206.753.82K0
EV to free cash flow
-122.58-49.36-116.06-113.840
Earnings yield
-0.01-0.02-0.01-0.010
Free cash flow yield
-0.01-0.02-0.01-0.010
Debt to equity
0.010.010.10.10
Debt to assets
0.010.010.080.080
Net debt to EBITDA
3.96-0.4-0.92-0.770
Current ratio
7.227.233.753.552.97
Interest coverage
-815.61-2.544.08-20.570
Income quality
0.771.10.6-0.020
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.031.820.640.590.62
Research and developement to revenue
0.240.190.210.160
Intangibles to total assets
0.020.020.020.020
Capex to operating cash flow
0.180.050.78-34.590
Capex to revenue
-0.02-0.02-0.07-0.140
Capex to depreciation
-0.37-0.32-1.19-2.320
Stock based compensation to revenue
00000
Graham number
5.4K7.21K4.59K4.94K0
ROIC
-0.03-0.04-0.03-0.03-0.03
Return on tangible assets
-0.02-0.05-0.02-0.02-0.02
Graham Net
2.6K2.41K2.26K1.97K0
Working capital
185.65B169.37B163.38B150.42B142.31B
Tangible asset value
331.87B323.83B317.98B309.32B307.41B
Net current asset value
174.33B165.76B159.97B147.73B138.68B
Invested capital
0.010.010.10.10
Average receivables
87.92B92.03B92.32B88.3B42.81B
Average payables
10.57B10.22B11.71B12.45B6.45B
Average inventory
50.18B47.15B49.39B51.47B25.53B
Days sales outstanding
152.38143.41169.26145.090
Days payables outstanding
23.7428.2336.9737.170
Days of inventory on hand
124.89115.82159.83147.210
Receivables turnover
0.590.630.530.620
Payables turnover
3.793.192.432.420
Inventory turnover
0.720.780.560.610
ROE
-0.03-0.05-0.02-0.03-0.03
Capex per share
-24.36-20.24-66.72-140.860

019170.KS Frequently Asked Questions

What is Shin Poong Pharm.Co.,Ltd. stock symbol ?

Shin Poong Pharm.Co.,Ltd. is a KR stock and trading under the symbol 019170.KS

What is Shin Poong Pharm.Co.,Ltd. stock quote today ?

Shin Poong Pharm.Co.,Ltd. stock price is $13110 today.

Is Shin Poong Pharm.Co.,Ltd. stock public?

Yes, Shin Poong Pharm.Co.,Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Similar Market Cap